Showing results (31-40 of 1,845) with videos related to
Sort By:
Pageof 185
Spine|December 16, 2004
Effect of altering titer, serotype, and promoter in recombinant adenoassociate virus gene therapy expression of spinal cord neurons and astrocytesJames S Harrop, David J Poulsen, Weidong Xiao, et al.Neuroreport|November 16, 2011
Specific knockdown of the D2 long dopamine receptor variantBart J Naughton, Keerthi Thirtamara-Rajamani, Chuansong Wang, et al.Neuron|October 27, 2004
Dysregulation of striatal dopamine signaling by amphetamine inhibits feeding by hungry miceClaire Matson Cannon, Luna Abdallah, Laurence H Tecott, et al.Journal of Neurophysiology|October 29, 2010
Potentiation of synaptic AMPA receptors induced by the deletion of NMDA receptors requires the GluA2 subunitWei Lu, John A Gray, Adam J Granger, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 10, 2008
HSP70 and constitutively active HSF1 mediate protection against CDCrel-1-mediated toxicityAlisha E Jung, Helen L Fitzsimons, Ross J Bland, et al.Neuron|September 29, 2011
Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivoJohn A Gray, Yun Shi, Hiroshi Usui, et al.Molecular and Cellular Neurosciences|July 26, 2008
Activity-dependent volume transmission by transgene NPY attenuates glutamate release and LTP in the subiculumAndreas T Sørensen, Irene Kanter-Schlifke, En-Ju D Lin, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 27, 2005
Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan diseaseMatthias Klugmann, Claudia B Leichtlein, C Wymond Symes, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2004
AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington diseaseAdrian P Kells, Dahna M Fong, Mike Dragunow, et al.The European Journal of Neuroscience|November 19, 2003
Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure developmentEn-Ju D Lin, Cristina Richichi, Deborah Young, et al.Pageof 185